Stryker price target raised to $360 from $315 at Canaccord

Canaccord analyst William Plovanic raised the firm’s price target on Stryker to $360 from $315 and keeps a Buy rating on the shares. The firm said they delivered a strong Q4 in the face of a tough Q4/22 comp, beating on the top and bottom lines and continuing to note healthy capital demand.